The study found:
• In patients undergoing both decompression and fusion, one-year readmission rate was 9.7 percent and two-year readmission rate was 14.6 percent.
• In patients only undergoing decompression, one- year readmission was 7.2 percent and two-year readmission rate was 12.5 percent.
• Of readmitted patients, including both fusion and non-fusion cohorts, 22 percent received pain management injection, 23 percent decompression and 56 percent fusion.
• In patients that were not readmitted, 25 percent received outpatient pain management injections within the three months following their surgery.
• Overall, spinal stenosis decompression readmission rates were found to be 8 to 10 percent per year.
The study ultimately concluded that fusion does not influence readmission rates.
More Articles on Spine:
10 Big Healthcare Policy Trends for Spine Surgeons to Know
Orthopaedic & Spine Institute Establishes Children’s Ward
Dr. Richard Spiro, Michael Horowitz Join PA Brain and Spine
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
